| The paradoxical role of IL-10 in immunity and cancer MH Mannino, Z Zhu, H Xiao, Q Bai, MR Wakefield, Y Fang Cancer letters 367 (2), 103-107, 2015 | 534 | 2015 |
| The role of IL-7 in immunity and cancer J Lin, Z Zhu, H Xiao, MR Wakefield, VA Ding, Q Bai, Y Fang Anticancer research 37 (3), 963-967, 2017 | 132 | 2017 |
| The role of IL-11 in immunity and cancer DH Xu, Z Zhu, MR Wakefield, H Xiao, Q Bai, Y Fang Cancer letters 373 (2), 156-163, 2016 | 121 | 2016 |
| The role of IL-37 in cancer VA Ding, Z Zhu, H Xiao, MR Wakefield, Q Bai, Y Fang Medical oncology 33, 1-7, 2016 | 47 | 2016 |
| The role of IL-29 in immunity and cancer NE Kelm, Z Zhu, VA Ding, H Xiao, MR Wakefield, Q Bai, Y Fang Critical Reviews in Oncology/Hematology 106, 91-98, 2016 | 42 | 2016 |
| Trichomonas vaginalis: a possible foe to prostate cancer Z Zhu, KT Davidson, A Brittingham, MR Wakefield, Q Bai, H Xiao, Y Fang Medical Oncology 33, 1-8, 2016 | 40 | 2016 |
| The past, present and future of immunotherapy for metastatic renal cell carcinoma AJ Chang, L Zhao, Z Zhu, K Boulanger, H Xiao, MR Wakefield, Q Bai, ... Anticancer research 39 (6), 2683-2687, 2019 | 30 | 2019 |
| IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer Y Fang, L Zhao, H Xiao, KM Cook, Q Bai, EJ Herrick, X Chen, C Qin, ... Medical Oncology 34, 1-9, 2017 | 30 | 2017 |
| Blueberry as a potential radiosensitizer for treating cervical cancer KT Davidson, Z Zhu, Q Bai, H Xiao, MR Wakefield, Y Fang Pathology & Oncology Research 25, 81-88, 2019 | 29 | 2019 |
| IL-39 acts as a friend to pancreatic cancer AA Manning, L Zhao, Z Zhu, H Xiao, CG Redington, VA Ding, ... Medical Oncology 36, 1-7, 2019 | 29 | 2019 |
| The role of interleukin-9 in cancer JE Lee, Z Zhu, Q Bai, TJ Brady, H Xiao, MR Wakefield, Y Fang Pathology & Oncology Research 26 (4), 2017-2022, 2020 | 24 | 2020 |
| IL‑33 notably inhibits the growth of colon cancer cells X Chen, K Lu, NJ Timko, DM Weir, Z Zhu, C Qin, JD Mann, Q Bai, H Xiao, ... Oncology letters 16 (1), 769-774, 2018 | 24 | 2018 |
| The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer VA Ding, Z Zhu, TA Steele, MR Wakefield, H Xiao, D Balabanov, Y Fang Medical Oncology 35, 1-8, 2018 | 19 | 2018 |
| Raspberry extract with potential antitumor activity against cervical cancer N Sham, C Qin, Z Zhu, CG Redington, H Xiao, Q Bai, MR Wakefield, ... Anticancer Research 41 (7), 3343-3348, 2021 | 15 | 2021 |
| A potential role for green tea as a radiation sensitizer for prostate cancer AC Schroeder, H Xiao, Z Zhu, Q Li, Q Bai, MR Wakefield, JD Mann, ... Pathology & Oncology Research 25, 263-268, 2019 | 14 | 2019 |
| IL-39 reduces proliferation and promotes apoptosis of bladder cancer by altering the activity of cyclin E and Fas H Xiao, H Alisic, BT Reiman, Z Deng, Z Zhu, NT Givens, Q Bai, A Tait, ... Anticancer Research 41 (5), 2239-2245, 2021 | 13 | 2021 |
| The role of IL-37 in non-cancerous diseases VA Ding, Z Zhu, AA Mantz, H Xiao, MR Wakefield, Q Bai, Y Fang Pathology & Oncology Research 23, 463-470, 2017 | 13 | 2017 |
| SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone BD Johnson, Z Zhu, M Lequio, CGD Powers, Q Bai, H Xiao, E Fajardo, ... Medical Oncology 39 (3), 32, 2022 | 12 | 2022 |
| Unveil the mysterious mask of cytokine-based immunotherapy for melanoma DH Xu, Z Zhu, H Xiao, MR Wakefield, Q Bai, MB Nicholl, VA Ding, Y Fang Cancer Letters 394, 43-51, 2017 | 12 | 2017 |
| Immunotherapy for non-small cell lung cancer: current agents and potential molecular targets NO Sham, L Zhao, Z Zhu, TM Roy, H Xiao, Q Bai, MR Wakefield, Y Fang Anticancer Research 42 (7), 3275-3284, 2022 | 9 | 2022 |
